Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review.
Beyer K, Moris L, Lardas M, Haire A, Barletta F, Scuderi S, Molnar M, Herrera R, Rauf A, Campi R, Greco I, Shiranov K, Dabestani S, van den Broeck T, Arun S, Gacci M, Gandaglia G, Omar MI, MacLennan S, Roobol MJ, Farahmand B, Vradi E, Devecseri Z, Asiimwe A, Zong J, Maclennan SJ, Collette L, NDow J, Briganti A, Bjartell A, Van Hemelrijck M; the PIONEER Consortium. Beyer K, et al. Among authors: bjartell a. BMJ Open. 2022 Apr 4;12(4):e058267. doi: 10.1136/bmjopen-2021-058267. BMJ Open. 2022. PMID: 35379637 Free PMC article.
MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. Catto JW, et al. Among authors: bjartell as. Eur Urol. 2011 May;59(5):671-81. doi: 10.1016/j.eururo.2011.01.044. Epub 2011 Feb 1. Eur Urol. 2011. PMID: 21296484 Review.
Tumor markers in prostate cancer I: blood-based markers.
Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ, Bjartell A. Shariat SF, et al. Among authors: bjartell a. Acta Oncol. 2011 Jun;50 Suppl 1(Suppl 1):61-75. doi: 10.3109/0284186X.2010.542174. Acta Oncol. 2011. PMID: 21604943 Free PMC article. Review.
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.
Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, Abrahamsson PA, Björk T, Gerdtsson A, Bjartell A, Gjertsson P, Höglund P, Lomsky M, Ohlsson M, Richter J, Sadik M, Morris MJ, Scher HI, Sjöstrand K, Yu A, Suurküla M, Edenbrandt L, Larson SM. Ulmert D, et al. Among authors: bjartell a. Eur Urol. 2012 Jul;62(1):78-84. doi: 10.1016/j.eururo.2012.01.037. Epub 2012 Jan 27. Eur Urol. 2012. PMID: 22306323 Free PMC article.
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study.
Bul M, Zhu X, Valdagni R, Pickles T, Kakehi Y, Rannikko A, Bjartell A, van der Schoot DK, Cornel EB, Conti GN, Boevé ER, Staerman F, Vis-Maters JJ, Vergunst H, Jaspars JJ, Strölin P, van Muilekom E, Schröder FH, Bangma CH, Roobol MJ. Bul M, et al. Among authors: bjartell a. Eur Urol. 2013 Apr;63(4):597-603. doi: 10.1016/j.eururo.2012.11.005. Epub 2012 Nov 12. Eur Urol. 2013. PMID: 23159452 Clinical Trial.
miQ--a novel microRNA based diagnostic and prognostic tool for prostate cancer.
Larne O, Martens-Uzunova E, Hagman Z, Edsjö A, Lippolis G, den Berg MS, Bjartell A, Jenster G, Ceder Y. Larne O, et al. Among authors: bjartell a. Int J Cancer. 2013 Jun 15;132(12):2867-75. doi: 10.1002/ijc.27973. Epub 2012 Dec 21. Int J Cancer. 2013. PMID: 23184647 Free article.
392 results